Pyrazole substituted hydroxamic acid derivatives as cyclooxygenase-2 and 5-lipoxygenase inhibitors
US6432999B1 · kind B1 · utility
12Cited by
53References
13Claims
0Family size
Assignee
Inventors
Key dates
| Filing date | Jun 11, 2001 |
| Grant date | Aug 13, 2002 |
| Priority date | — |
| Expiry date | Jun 11, 2021 |
Classification
- Technology area (CPC B)Performing Operations; Transporting
- CPC primaryB64C2027/004
- WIPO fieldTransport
- WIPO sectorMechanical engineering
Abstract
This invention is in the field of antiinflammatory pharmaceutical agents and specifically relates to compounds, compositions and methods for treating disorders mediated by cyclooxygenase-2 or 5-lipoxygenase, such as inflammation.
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.